Cancer Screening Delays Due to COVID-19 Fuel Rise in Diagnoses
Delays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases.
Read MorePosted by Chris Wolski | May 29, 2023 | Cancer |
Delays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases.
Read MorePosted by Chris Wolski | May 25, 2023 | Molecular Diagnostics |
The award through the NIH’s RADx Tech program, will support Domus Diagnostics’ at-home molecular test for clinical trial readiness.
Read MorePosted by Chris Wolski | May 23, 2023 | Infectious Diseases |
Regular diagnostic testing and self-isolation can be more effective than school and business closures in combating disease outbreaks.
Read MorePosted by Chris Wolski | May 23, 2023 | Sepsis |
Researchers presented data that validate a rapid diagnostic test for sepsis at the American Thoracic Society 2023 International Conference.
Read MorePosted by Chris Wolski | May 19, 2023 | Covid 19, Flu & Respiratory Infections |
Hologic Inc. announced that the FDA has granted 510(k) clearance for the company’s Panther Fusion SARS-CoV-2/Flu A/B/RSV assay.
Read More